NeuroOne Medical Technologies Corporation (NASDAQ:NMTC) Q1 2025Management ViewCEO Dave Rosa highlighted the strong performance ...

Zimmer Biomet Holdings Inc (NYSE:ZBH), a leading player in the medical devices sector with a market capitalization of $22.12 billion, has been making strategic moves to strengthen its market position ...

Success in this area could not only drive direct revenue growth from the ROSA system sales but also increase demand for Zimmer Biomet's complementary products and implants used in shoulder procedures.

Q4 2024 Earnings Call Transcript February 6, 2025 Zimmer Biomet Holdings, Inc. beats earnings expectations. Reported EPS is ...

This cautious approach is primarily attributed to challenges associated with the implementation of a new Enterprise Resource Planning (ERP) system ... to affect Zimmer Biomet's ROSA robotic ...

Recently, Zimmer Biomet agreed to acquire Paragon 28, Inc. FNA for an upfront cash payment of $13.00 per share, corresponding to an equity value of approximately $1.1 billion and an enterprise value ...

Good morning, ladies and gentlemen, and welcome to the Zimmer Biomet Fourth Quarter 2024 Earnings Conference Call. [Operator Instructions] As a reminder, this conference is being recorded today, ...

This cautious approach is primarily attributed to challenges associated with the implementation of a new Enterprise Resource Planning (ERP) system. The transition ... is not expected to affect Zimmer ...

The company is expected to have generated strong sales with Z1, the new triple-taper hip system ... Zimmer Biomet received FDA clearance for Persona SoluTion Porous Plasma Spray Femur, a total ...

It is a dominant player in the orthopedic sector, leading the market with a 36% share in knee implants ... robotic system in ROSA, Robotic Surgical Assistant. Additionally, Zimmer Biomet Holdings ...